Dr. Reddy's Laboratories
CompanyIndiaFounded 1984
Dr. Reddy's Laboratories develops 5 assets, the furthest approved (celecoxib in acute pain). Mostly small molecule acting on inflammation, FKBP1A and PTGS2; based in India, founded in 1984.
- 5
- Assets
- Furthest
- Approved
- 33
- Trials
- 0
- Signals
Pipeline
5Selective cyclooxygenase-2 inhibitor reducing prostaglandin synthesis to relieve pain and inflammation
Approved, Small molecule, Inflammation, PTGS2, acute pain, adenomatous polyposis coli
Binds synaptic vesicle protein SV2A to modulate neurotransmitter release and reduce seizures.
Approved, Small molecule, SV2A, epilepsy, Epilepsy, Idiopathic Generalized
Inhibits HMG-CoA reductase to reduce endogenous cholesterol synthesis.
Approved, Small molecule, Lipid and ceramide metabolism, HMGCR, actue coronary syndrome (Phase 3), hypercholesterolemia (Phase 3)
2 more assets
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms11
- Trials40
- Signals7
- Similar companies6
Updated 13 Oct 2026 · 244 sources